453 related articles for article (PubMed ID: 24373601)
21. Serious infections in patients with inflammatory bowel disease receiving anti-tumor-necrosis-factor-alpha therapy: an Australian and New Zealand experience.
Lawrance IC; Radford-Smith GL; Bampton PA; Andrews JM; Tan PK; Croft A; Gearry RB; Florin TH
J Gastroenterol Hepatol; 2010 Nov; 25(11):1732-8. PubMed ID: 21039834
[TBL] [Abstract][Full Text] [Related]
22. Validity, reliability, and responsiveness of the work productivity and activity impairment questionnaire in Crohn's disease.
Reilly MC; Gerlier L; Brabant Y; Brown M
Clin Ther; 2008 Feb; 30(2):393-404. PubMed ID: 18343277
[TBL] [Abstract][Full Text] [Related]
23. Tumour necrosis factor antagonists and inflammatory bowel diseases: a national practice survey.
Oussalah A; Roblin X; Laharie D; Filippi J; Flamant M; Faure P; Phelip JM; Bigard MA; Peyrin-Biroulet L
Aliment Pharmacol Ther; 2009 Oct; 30(8):854-63. PubMed ID: 19764940
[TBL] [Abstract][Full Text] [Related]
24. Cutaneous manifestations in inflammatory bowel diseases: eight cases of psoriasis induced by anti-tumor-necrosis-factor antibody therapy.
Passarini B; Infusino SD; Barbieri E; Varotti E; Gionchetti P; Rizzello F; Morselli C; Tambasco R; Campieri M
Dermatology; 2007; 215(4):295-300. PubMed ID: 17911986
[TBL] [Abstract][Full Text] [Related]
25. Health-related quality of life during natalizumab maintenance therapy for Crohn's disease.
Feagan BG; Sandborn WJ; Hass S; Niecko T; White J
Am J Gastroenterol; 2007 Dec; 102(12):2737-46. PubMed ID: 18042106
[TBL] [Abstract][Full Text] [Related]
26. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial.
Irvine EJ; Zhou Q; Thompson AK
Am J Gastroenterol; 1996 Aug; 91(8):1571-8. PubMed ID: 8759664
[TBL] [Abstract][Full Text] [Related]
27. Restoration of quality of life of patients with inflammatory bowel disease after one year with antiTNFα treatment.
Casellas F; Robles V; Borruel N; Torrejón A; Castells I; Navarro E; Guarner F
J Crohns Colitis; 2012 Oct; 6(9):881-6. PubMed ID: 22398074
[TBL] [Abstract][Full Text] [Related]
28. Increased arterial stiffness in inflammatory bowel diseases is dependent upon inflammation and reduced by immunomodulatory drugs.
Zanoli L; Rastelli S; Inserra G; Lentini P; Valvo E; Calcagno E; Boutouyrie P; Laurent S; Castellino P
Atherosclerosis; 2014 Jun; 234(2):346-51. PubMed ID: 24732573
[TBL] [Abstract][Full Text] [Related]
29. Is there any association between impaired health-related quality of life and non-adherence to medical therapy in inflammatory bowel disease?
Horváth G; Farkas K; Hollósi R; Nagy F; Szepes Z; Papp M; Palatka K; Miheller P; Lakatos L; Szamosi T; Nyári T; Wittmann T; Molnár T
Scand J Gastroenterol; 2012 Nov; 47(11):1298-303. PubMed ID: 22935014
[TBL] [Abstract][Full Text] [Related]
30. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
Burisch J
Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
[TBL] [Abstract][Full Text] [Related]
31. Retesting for latent tuberculosis in patients with inflammatory bowel disease treated with TNF-α inhibitors.
Papay P; Primas C; Eser A; Novacek G; Winkler S; Frantal S; Angelberger S; Mikulits A; Dejaco C; Kazemi-Shirazi L; Vogelsang H; Reinisch W
Aliment Pharmacol Ther; 2012 Nov; 36(9):858-65. PubMed ID: 22978645
[TBL] [Abstract][Full Text] [Related]
32. [Chronic inflammatory bowel diseases. Update on evidence-based therapy].
MMW Fortschr Med; 2005 Apr; 147(17):58-9. PubMed ID: 15903063
[No Abstract] [Full Text] [Related]
33. Health- and vision-related quality of life in patients receiving infliximab therapy for Behcet uveitis.
Sakai T; Watanabe H; Kuroyanagi K; Akiyama G; Okano K; Kohno H; Tsuneoka H
Br J Ophthalmol; 2013 Mar; 97(3):338-42. PubMed ID: 23314623
[TBL] [Abstract][Full Text] [Related]
34. [Treatment of chronic inflammatory bowel diseases].
Lémann M
Bull Acad Natl Med; 2007 Jun; 191(6):1125-41; discussion 1141. PubMed ID: 18402168
[TBL] [Abstract][Full Text] [Related]
35. Effect of intestinal resection on quality of life in Crohn's disease.
Wright EK; Kamm MA; De Cruz P; Hamilton AL; Ritchie KJ; Krejany EO; Gorelik A; Liew D; Prideaux L; Lawrance IC; Andrews JM; Bampton PA; Sparrow MP; Florin TH; Gibson PR; Debinski H; Gearry RB; Macrae FA; Leong RW; Kronborg I; Radford-Smith G; Selby W; Johnston MJ; Woods R; Elliott PR; Bell SJ; Brown SJ; Connell WR; Desmond PV
J Crohns Colitis; 2015 Jun; 9(6):452-62. PubMed ID: 25855073
[TBL] [Abstract][Full Text] [Related]
36. Psoriasis associated with anti-tumour necrosis factor therapy in inflammatory bowel disease: a new series and a review of 120 cases from the literature.
Cullen G; Kroshinsky D; Cheifetz AS; Korzenik JR
Aliment Pharmacol Ther; 2011 Dec; 34(11-12):1318-27. PubMed ID: 21957906
[TBL] [Abstract][Full Text] [Related]
37. Role of thiopurine and anti-TNF therapy in lymphoma in inflammatory bowel disease.
Herrinton LJ; Liu L; Weng X; Lewis JD; Hutfless S; Allison JE
Am J Gastroenterol; 2011 Dec; 106(12):2146-53. PubMed ID: 22031357
[TBL] [Abstract][Full Text] [Related]
38. How frequently do tuberculosis screening tests convert in inflammatory bowel disease patients on anti-tumour necrosis factor-alpha? A pilot study.
Bermejo F; Algaba A; Chaparro M; Taxonera C; Garrido E; García-Arata I; Guerra I; Gisbert JP; Olivares D; de-la-Poza G; López-Sanromán A
Dig Liver Dis; 2013 Sep; 45(9):733-7. PubMed ID: 23587496
[TBL] [Abstract][Full Text] [Related]
39. TNF antagonists in the treatment of inflammatory bowel disease: results of a survey of gastroenterologists in the French region of Lorraine.
Peyrin-Biroulet L; Oussalah A; Boucekkine T; Bigard MA
Gastroenterol Clin Biol; 2009 Jan; 33(1 Pt 1):23-30. PubMed ID: 19118965
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of hepatitis B vaccination and revaccination and factors impacting on response in patients with inflammatory bowel disease.
Gisbert JP; Villagrasa JR; Rodríguez-Nogueiras A; Chaparro M
Am J Gastroenterol; 2012 Oct; 107(10):1460-6. PubMed ID: 23034605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
